Komori
Sigma Koki (7713) · FactAdvanced

Continuation of R&D Activities and R&D Expenses

First written in FY2017-Q3. 16 of 30 entries say "Restated". Latest entry: FY2026.

30entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q3 – FY2021-Q3OtherFY2024-Q1 – FY2026-H12017: 220172018: 420182019: 420192020: 320202021: 420212022: 420222023: 420232024: 220242025: 120252026: 22026
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 191 companies write about · 0 as a headwind · 180 as a tailwind

41 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 191 companies compared. The sentences above are computed from all 191.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Group's research and development expenses by business segment during the current consolidated fiscal year were ¥223 million for the Component Parts Business and ¥139 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses were ¥223 million for the Component Parts Business and ¥139 million for the System Products Business, for a total of ¥362 million, up from approximately ¥335 million in the previous year.
  2. FY2026-H1Slight increase in R&D expensesAnnual report

    「The amount of the Group's research and development activities during the current interim consolidated accounting period was ¥173 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」

    Research and development expenses for the cumulative interim period were ¥173 million, up ¥2 million from ¥171 million in the year-earlier period. It was stated that there were no material changes in the status of research and development activities.
  3. FY2025-H1RestatedAnnual report

    「The amount of the Group's research and development activities during the current interim consolidated accounting period was ¥171 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」

    Research and development expenses for the cumulative interim period were ¥171 million, unchanged from the year-earlier period, and it was stated that there were no material changes in the status of research and development activities.
  4. FY2024-Q3Decrease in R&D expensesAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥246 million.」

    Research and development expenses for the cumulative third quarter were ¥246 million, down from ¥274 million in the year-earlier period. It was stated that there were no material changes in the status of research and development activities.
  5. FY2024-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥171 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    It was reconfirmed that research and development expenses for the cumulative second quarter were ¥171 million and that there were no material changes in the status of research and development activities.
  6. FY2024-Q1R&D spending increasedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥89 million.」

    Research and development expenses for the cumulative first quarter were ¥89 million, up from ¥80 million in the year-earlier period.
  7. FY2023AdvancedAnnual report

    「The Group's research and development expenses by business segment during the current consolidated fiscal year were ¥205 million for the Component Parts Business and ¥160 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses were ¥205 million for the Component Parts Business and ¥160 million for the System Products Business, and development progressed on electric mirror mounts, optical inspection systems, transscale scopes and medical equipment.
  8. FY2023-Q3R&D spending increasedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥274 million.」

    Research and development expenses for the cumulative third quarter were ¥274 million, up from ¥263 million in the year-earlier period.
  9. FY2023-Q2R&D spending increasedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥190 million.」

    Research and development expenses for the cumulative second quarter were ¥190 million, up from ¥178 million in the year-earlier period.
  10. FY2023-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥80 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative first quarter were ¥80 million and that there were no material changes in the status of research and development activities.
  11. FY2022AdvancedAnnual report

    「The Group's research and development expenses by business segment during the current consolidated fiscal year were ¥207 million for the Component Parts Business and ¥150 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses were ¥207 million for the Component Parts Business and ¥150 million for the System Products Business, with the composition changing from ¥181 million and ¥153 million, respectively, in the previous fiscal year.
  12. FY2022-Q3R&D spending increasedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥263 million.」

    Research and development expenses for the cumulative third quarter were ¥263 million, up from ¥243 million in the year-earlier period.
  13. FY2022-Q2R&D spending increasedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥178 million.」

    Research and development expenses for the cumulative second quarter were ¥178 million, up from ¥164 million in the year-earlier period.
  14. FY2022-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥79 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development expenses for the cumulative first quarter were ¥79 million, the same as in the year-earlier period, and there were no material changes in the status of research and development activities.
  15. FY2021AdvancedAnnual report

    「The Group's research and development expenses by business segment during the current consolidated accounting period were ¥181 million for the Component Parts Business and ¥153 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses were ¥181 million for the Component Parts Business and ¥153 million for the System Products Business, and both businesses advanced the development of new and improved products.
  16. FY2021-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥243 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    The company states that research and development expenses for the cumulative third quarter were ¥243 million and that there were no material changes in the status of research and development activities.
  17. FY2021-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥164 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development expenses for the cumulative second quarter were ¥164 million, and it was reconfirmed that there were no material changes in the status of research and development activities.
  18. FY2021-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥71 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development expenses for the cumulative first quarter were ¥71 million, and there were no material changes in the status of research and development activities.
  19. FY2020-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥241 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    The company states that research and development expenses for the cumulative third quarter were ¥241 million and that there were no material changes in the status of research and development activities.
  20. FY2020-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥164 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    The company states that research and development expenses for the cumulative second quarter were ¥164 million and that there were no material changes in the status of research and development activities.
  21. FY2020-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥79 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    The company reconfirms that research and development expenses for the cumulative first quarter were ¥79 million and that there were no material changes in the status of research and development activities.
  22. FY2019Details of full-year research and development expenses and resultsAnnual report

    「The Group's research and development expenses by business segment during the current consolidated fiscal year were ¥171 million for the Component Parts Business and ¥147 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses were ¥171 million for the Component Parts Business and ¥147 million for the System Products Business. The company also provided details of development activities, including a nanostage, microscope systems and optical inspection equipment.
  23. FY2019-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥237 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative third quarter were ¥237 million and that there were no material changes in the status of research and development activities.
  24. FY2019-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥159 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative second quarter were ¥159 million and that there were no material changes in the status of research and development activities.
  25. FY2019-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥65 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative first quarter were ¥65 million and that there were no material changes in the status of research and development activities.
  26. FY2018Details of research and development expenses and development activitiesAnnual report

    「The Group's research and development expenses by business segment during the current consolidated accounting period were ¥156 million for the Component Parts Business and ¥143 million for the System Products Business. The main research and development activities were as follows.」

    Research and development expenses for the full year are shown by business, along with specific development activities for both the Component Parts and System Products businesses.
  27. FY2018-Q3RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥223 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative third quarter were ¥223 million and that there were no material changes in the status of research and development activities.
  28. FY2018-Q2RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥157 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative second quarter were ¥157 million and that there were no material changes in the status of research and development activities.
  29. FY2018-Q1RestatedAnnual report

    「The amount of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥65 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative first quarter were ¥65 million and that there were no material changes in the status of research and development activities.
  30. FY2017-Q3First statedAnnual report

    「The amount of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥205 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    The company states that research and development activity expenses for the cumulative third quarter were ¥205 million and that there were no material changes in the status of research and development activities.
Moved together

"Expansion of System Products and Modules" moved the same way as this thread, in the same document, in 4 of its 30 moves.

444433★123456
  1. ★This thread
  2. 1Expansion of System Products and Modules4×
  3. 2In-House Production of Core Components, Basic Technology Development, and Creation of High-Value-Added Products4×
  4. 3Strengthening Internal Control, Compliance and Corporate Governance4×
  5. 4Passing on Technical Skills and Developing Talent Through Training for Junior and Mid-Career Employees4×
  6. 5Improving the Operating Margin3×
  7. 6Production Efficiency, Strengthened Purchasing, and Expense Reduction3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sigma Koki yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of R&D Activities and R&D Expenses | SIGMA KOKI CO.,LTD. (7713) | Komori